Glycoprotein
Showing 1 - 25 of 1,591
Glycosphingolipid and Glycoprotein Lysosomal Storage Disorders
Recruiting
- Neurological Regression
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 14, 2023
Serum Leucine-rich Alpha-2 Glycoprotein Levels on IBD
Recruiting
- LRG Levels
- serum leucine-rich alpha-2 glycoprotein (LRG) levels
-
Komagane, Nagano, JapanShowa Inan General Hospital
May 2, 2022
Gastrointestinal Stromal Tumors Trial in Seoul (Paclitaxel)
Recruiting
- Gastrointestinal Stromal Tumors
-
Seoul, Korea, Republic ofAsan Medical Center
Dec 30, 2022
Ebola Virus Disease Trial in Kenema (rVSVDG-ZEBOV-GP Ebola Virus Vaccine (ERVEBO))
Not yet recruiting
- Ebola Virus Disease
- rVSVDG-ZEBOV-GP Ebola Virus Vaccine (ERVEBO)
-
Kenema, Eastern, Sierra LeoneKenema Government Hospital
Aug 7, 2023
Digestion, Gut Microbiota Trial in Shanghai (Commercially Available Starter Infant Formula)
Recruiting
- Digestion
- Gut Microbiota
- Commercially Available Starter Infant Formula
-
Shanghai, ChinaShanghai Public Health Clinical Center
Aug 25, 2022
Epstein-Barr Virus Infection, Infectious Mononucleosis, Herpesvirus Trial run by the National Institute of Allergy and
Not yet recruiting
- Epstein-Barr Virus Infection
- +2 more
- Matrix-M1 Adjuvant
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Ebola Virus Disease Trial in Baltimore (HPIV3/?HNF/EbovZ GP vaccine, Placebo)
Suspended
- Ebola Virus Disease
- HPIV3/ΔHNF/EbovZ GP vaccine
- Placebo
-
Baltimore, Maryland
- +1 more
Mar 2, 2022
Neurodegenerative Diseases, Alzheimer, Parkinson Disease Trial in Groningen ([18F]MC225)
Recruiting
- Neurodegenerative Diseases
- +3 more
-
Groningen, NetherlandsUniversity Medical Center Groningen
May 9, 2023
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) Trial in Germany, Italy, United States (Satralizumab,
Recruiting
- Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)
- Satralizumab
- Placebo
-
Washington, District of Columbia
- +3 more
Aug 2, 2022
Cushing Syndrome, Tumors Trial (Dabigatran Etexilate, Relacorilant)
Not yet recruiting
- Cushing Syndrome
- Neoplasms
- Dabigatran Etexilate
- Relacorilant
- (no location specified)
Apr 22, 2022
Gastrointestinal Stromal Tumors Trial in Seoul (Rivoceranib Mesylate, Paclitaxel)
Not yet recruiting
- Gastrointestinal Stromal Tumors
- Rivoceranib Mesylate, Paclitaxel
-
Seoul, Korea, Republic ofAsan Medical Center, University of Ulsan College of Medicine
Jun 7, 2023
Immunoglobulin M-Anti-myelin-associated-glycoprotein(MAG)
Recruiting
- Immunoglobin M Anti-myelin-associated-glycoprotein Peripheral Neuropathy
- Clinical examination and patients' questionnaires regarding activity and participation (preliminary Immunogloblin M (IgM)-Rasch-built overall Disability Scale (RODS), and finalized IgM-RODS)
-
Bron, France
- +1 more
Mar 22, 2022
Diagnostic Importance of Circulating Human Leucine-rich
Recruiting
- Appendicitis Acute
- Blood specimen collection
- Saliva specimen collection
-
Split, Splitsko-dalmatinska, CroatiaUniversity Hospital Split
Mar 29, 2022
Monoclonal Gammopathy of Uncertain Significance Trial in Utrecht (Zanubrutinib Oral Product)
Not yet recruiting
- Monoclonal Gammopathy of Uncertain Significance
- Zanubrutinib Oral Product
-
Utrecht, NetherlandsUniversity Medical Center Utrecht
Jul 6, 2023
Periodontal Diseases Trial in Izmir (saliva obtaining)
Active, not recruiting
- Periodontal Diseases
- saliva obtaining
-
İzmir, Çiğli, TurkeyIzmir Katip Çelebi University Department of Periodontology
Mar 21, 2023
Osteosarcoma Trial in Italy (Mifamurtide arm, 3 drugs arm)
Active, not recruiting
- Osteosarcoma
- Mifamurtide arm
- 3 drugs arm
-
Candiolo, Torino, Italy
- +10 more
Sep 16, 2022
Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOG-AD) Trial in Worldwide (Rozanolixizumab, Placebo)
Recruiting
- Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOG-AD)
- Rozanolixizumab
- Placebo
-
Scottsdale, Arizona
- +43 more
Feb 2, 2023
Prostate Cancer Trial in Chisinau (enzalutamide, enzalutamide Placebo, digoxin)
Completed
- Prostate Cancer
- enzalutamide
- +3 more
-
Chisinau, Moldova, Republic ofSite MD37301
Jan 14, 2022
Myocardial Ischemia, Acute Coronary Syndrome Trial (Eptifibatide (Integrilin), Placebo)
Completed
- Myocardial Ischemia
- Acute Coronary Syndrome
- Eptifibatide (Integrilin)
- Placebo
- (no location specified)
Feb 7, 2022
Initial Clinical Presentation of Inflammatory Optic Neuritis
Completed
- Optic Neuritis
- Non interventional study
-
Angers, France
- +7 more
Feb 16, 2022
HIV Trial in Saint Louis (gp160 Vaccine (MicroGeneSys))
Completed
- HIV Infections
- gp160 Vaccine (MicroGeneSys)
-
Saint Louis, MissouriSt. Louis Univ. School of Medicine AVEG
Oct 27, 2021
HIV Trial in Saint Louis (gp160 Vaccine (Immuno-AG))
Completed
- HIV Infections
- gp160 Vaccine (Immuno-AG)
-
Saint Louis, MissouriSt. Louis Univ. School of Medicine AVEG
Oct 28, 2021
Healthy Participants Trial in Daytona Beach (AMG 510, Digoxin)
Completed
- Healthy Participants
- AMG 510
- Digoxin
-
Daytona Beach, FloridaCovance Clinical Research Unit, Inc
Oct 25, 2022
HIV Trial in Saint Louis, Pittsburgh (gp160 Vaccine (MicroGeneSys))
Completed
- HIV Infections
- gp160 Vaccine (MicroGeneSys)
-
Saint Louis, Missouri
- +1 more
Oct 27, 2021